| Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia. | |
MedLine Citation:
|
PMID: 7249296 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We compared the relationship between plasma levels of procainamide and suppression or prevention of various forms of ventricular arrhythmias in 18 patients, six of whom had premature ventricular complexes (PVCs) during acute myocardial infarction (AMI), six of whom had PVCs in the setting of stable chronic ischemic heart disease (CIHD), and six of whom had recurrent symptomatic ventricular tachycardia (VT) with chronic PVCs between episodes of VT. The mean plasma level of procainamide required for 85% suppression of PVCs in the AMI patients was 5.0 +/- 0.5 micrograms/ml, while that required for the CIHD patients was 9.3 +/- 0.7 micrograms/ml (p less than 0.05). The mean plasma level required for prevention of spontaneous episodes of symptomatic sustained tachycardia in the VT group was 9.1 +/- 3.4 micrograms/ml, while the mean level required for 85% suppression of PVCs in the same patients was 14.9 +/- 3.8 micrograms/ml (p less than 0.01). In the VT group, PVC frequency was decreased by a mean of only 36% (range 11-63%) at plasma levels of procainamide sufficient to prevent spontaneous VT. The relationship between plasma levels of procainamide and PVC suppression appears to be different in AMI and CIHD patients; furthermore, a high degree of PVC suppression is not a necessary endpoint of antiarrhythmic therapy when attempting to protect patients against recurrent symptomatic VT. |
Authors:
|
R J Myerburg; K M Kessler; I Kiem; K C Pefkaros; C A Conde; D Cooper; A Castellanos |
Related Documents
:
|
21345656 - Microscale plasma-initiated patterning of electrospun polymer scaffolds. 21310866 - Low plasma vitamin b-6 status affects metabolism through the kynurenine pathway in card... 21545246 - Neonatal plasma tsh - estimated upper reference intervals for diagnosis and follow up o... 6181326 - Differences in color vision impairment caused by digoxin, digitoxin, or pengitoxin. 6832716 - Changes in iga following varying degrees of biliary obstruction in the rat. 2025236 - Naturally occurring benzodiazepines in human milk. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Circulation Volume: 64 ISSN: 0009-7322 ISO Abbreviation: Circulation Publication Date: 1981 Aug |
Date Detail:
|
Created Date: 1981-09-25 Completed Date: 1981-09-25 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 0147763 Medline TA: Circulation Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 280-90 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Aged Chronic Disease Coronary Disease / drug therapy Dose-Response Relationship, Drug Electrocardiography* Female Heart Ventricles / physiopathology Humans Male Middle Aged Myocardial Infarction / drug therapy Procainamide / blood*, therapeutic use Recurrence Tachycardia / drug therapy* |
| Grant Support | |
ID/Acronym/Agency:
|
HL 18769-06/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
51-06-9/Procainamide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cardiac infarction injury score: an electrocardiographic coding scheme for ischemic heart disease.
Next Document: Ventricular premature complexes and sudden death after myocardial infarction.